Quality of life in patients with chronic thromboembolic pulmonary hypertension

Stephen C. Mathai, Hossein Ardeschir Ghofrani, Eckhard Mayer, Joanna Pepke-Zaba, Sylvia Nikkho, Gérald Simonneau

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations


Patients with chronic thromboembolic pulmonary hypertension (CTEPH) experience debilitating symptoms that have a negative impact on their quality of life (QoL) in terms of physical capability, psychological wellbeing and social relationships. The use of QoL measurement tools is important in the assessment of treatment efficacy and in guiding treatment decisions. However, despite the importance of QoL, particularly to the patient, it remains under-reported in clinical studies of CTEPH therapy. CTEPH is unique in pulmonary hypertension in that it is potentially curable by surgery; however, a proportion of patients either have residual PH following surgery or are not operable. Although some patients with CTEPH have been treated off-label with pulmonary arterial hypertension-specific therapies, there have been few randomised controlled trials of these therapies in patients with CTEPH. Moreover, in these trials QoL outcomes are variably assessed, and there is little consistency in the tools used. Here we review the assessment of QoL in patients with CTEPH and the tools that have been used. We also discuss the effect of surgical intervention and medical therapies on QoL. We conclude that further studies of QoL in patients with CTEPH are needed to further validate the optimal QoL tools.

Original languageEnglish (US)
Pages (from-to)526-537
Number of pages12
JournalEuropean Respiratory Journal
Issue number2
StatePublished - Aug 1 2016

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Quality of life in patients with chronic thromboembolic pulmonary hypertension'. Together they form a unique fingerprint.

Cite this